About Us

VIRAPUR serves the research, diagnostic and vaccine communities, providing specialized viral reagents including live virus preparations and quantitated viral nucleic acids. We perform antiviral testing of small molecules against virus panels. We also assist in viral clearance process development studies. We specialize in upper respiratory viruses, especially influenzas, RSV, CMV as well as adenovirus, herpes viruses, phage and many other biosafety level 2 and 3 agents. We invented the original adenovirus purification ViraKits™ in 2000 and the original AAV purification ViraKit™ line in 2004.

Marylou GibsonMarylou Gibson, Ph.D., President and Chief Scientific Officer

Marylou Gibson trained in adenovirology at the University of Illinois, with post-doctoral training in the herpesviruses at the University of Michigan and University of Chicago. Her many years of experience in the biotech industry took her from developing veterinary and human herpesvirus vaccines to Bristol-Myers Squibb then Immunex/Amgen where she was on the team that developed the cell line secreting the drug Enbrel. She was instrumental in the startup of UC San Diego's GeneTherapy Clinical Manufacturing program which later became Molecular Medicine Bioservices/SAFC Pharma. She co-founded VIRAPUR based on her invention of the adenovirus purification kit.

Rob RobbinsRob Robbins, Chief Financial Officer and Operations Manager

With ten years in biotech, he trained in accounting at Duke University, obtained a Masters degree in Business from American University, and studied in finance at University of California, San Diego. Rob served in the US Navy Supply Corps and led several forums involving major Defense contractors, program sponsors, auditors and contracting officers for acquisition process improvements. As Senior Manager at KPMG LLP from 1998-2003, managed new accounts in global IT programs with > $400M total budget. Responsible for Total Ownership Cost models, congressional budget exhibits and spend plans. Co-Founder and prior CFO of PacificGMP, a biologics contract manufacturing organization. Rob has served on several Boards including the National Contract Management Association.

Joan RobbinsJoan Robbins, Ph.D., Scientific Advisor at VIRAPUR and Senior Director Cancer Biology at Tocogen, Inc.

Joan received a B.S. degree in genetics from the University of California, Davis, and a Ph.D. degree in genetics from the George Washington University, Washington DC. She served as Senior Vice President and Chief Scientific Officer of ADVENTRX Pharmaceuticals, Inc., a specialty pharmaceutical company developing oncology and HIV products. At Immusol, Inc. she directed drug discovery and development and successfully progressed drug candidates into Phase 1, 2 & 3 human trials. Prior experience includes retroviral immuno-gene therapy for cancer at Chiron, Research Fellow at the Garvin Institute for Medical Research, Centre for Immunology in Sydney, Australia, and Microbiologist at the Laboratory of Tumor Immunology and Biology, National Cancer Institute in Bethesda, Maryland. She has published over 20 scientific publications and is an inventor on 12 patents and applications. She is co-founder of VIRAPUR and PacificGMP, a biologics contract manufacturing organization.